IMUNI Pty Ltd fined $13,320 for alleged unlawful advertising of a complementary medicine

The Therapeutic Goods Administration (TGA) has issued one infringement notice for $13,320 to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.

It is alleged that the medicine was advertised for preventing upper respiratory tract infections in infants and children. This therapeutic claim was not permitted to be used for the medicine. Listed medicines can only use pre-approved permitted indications (therapeutic claims) that have been listed in the Australian Register of Therapeutic Goods (ARTG) entry for the medicine.

Sponsors and advertisers of listed medicines must not use therapeutic claims in advertising that breach the requirements of the Therapeutic Goods Act 1989 and the Advertising Code.

The TGA conducts post-market compliance reviews of listed medicines and investigates potential non-compliance identified during routine monitoring of new or changed listings of medicines on the ARTG.

If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA. The TGA encourages the reporting of suspected non-compliant advertising.

Contact for members of the media:

• Email: news@health.gov.au
• Phone: 02 6289 7400